Sidenav Mini


MONEY Tuesday May 24th 2022 Morning Stock Newsletter

๐ŸŒŸ๐ŸŒŸ Goooooood morning Team and Happy Tuesday ๐ŸŒŸ๐ŸŒŸ

Welcome back to the BEST Trading Community in the WORLD ๐Ÿ˜Ž I hope you all had an awesome evening and that you are ready to rock and roll on this beautiful Tuesday!

Yesterday was an amazing day inside of chat ๐Ÿคฉ ๐Ÿ’ช This is the time to make some BIG TIME profits in the market! Keep up that amazing work team and letโ€™s have an even better day today!

Get ๐Ÿ”ฅ FIRED ๐Ÿ”ฅup team because we are hitting it hard today.

Yesterdays trader of the day – George with a $880+ profit! WWWOOOOO


Stock futures indicate the sell-off resuming on Wall Street after Mondayโ€™s brief rebound

FANTASTIC NEWS $SWTX – SpringWorks Therapeutics Announces Nirogacestat Achieved Primary And All Key Secondary Endpoints In Phase 3 DeFi Trial In Adult Patients With Progressing Desmoid Tumors

$GFAI – Guardforce AI Announces Definitive Agreements to Acquire Eight Companies in China

$BIMI – BZ: BIMI International Shares Up 134% Premarket; No News to Account for the Move

$CTEK – CynergisTek (CTEK) said late Monday it agreed to be acquired by Clearwater Compliance in an all-cash deal valuing the cybersecurity company at $17.7 million. Under the terms of the deal, CynergisTek stockholders will receive $1.25 per share, representing a roughly 112% premium over the company’s May 20 closing share price. NOT WORTH YOUR TIME

$PHGE – BiomX Announces Corporate Restructuring

$SNAP – Snap Issues Profit Warning on Economic Conditions Including Soaring Inflation — 2nd Update

$FB $SNAP $TWTR – Shares of social media and digital advertising companies took a hit in premarket trading as investors digested a mid- quarter warning from Snap Inc. , which said revenue and adjusted earnings would likely come in below the projections it issued about a month earlier.

$BBY – MW Best Buy beats on revenue, lowers guidance

My top stocks for the day
We need to be looking for press releases that have to do with “monkeypox”. That could be our next big play as $SIGA has a press release Thursday ( U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment of smallpox. The IV formulation is an important option for those who are unable to swallow the oral capsules of TPOXX.)

$SIGAย is still on HIGH WATCH for a possible short squeeze. This stock was ETB on all main stream brokers Thursday and Friday. When a stock is ETB, newer traders get excited and rush into the short side (because there is rarely ever a penny stock that can be shorted).



Earnings this Week